GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » Net Interest Margin (Bank Only) %

Vidac Pharma Holding (STU:T9G) Net Interest Margin (Bank Only) %


View and export this data going back to 2023. Start your Free Trial

What is Vidac Pharma Holding Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.


Vidac Pharma Holding Business Description

Industry
Traded in Other Exchanges
N/A
Address
Wenlock Road, 20-22, London, GBR, N1 7GU
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.